Literature DB >> 32163698

SARS-CoV-2 Infection among Travelers Returning from Wuhan, China.

Oon-Tek Ng1,2, Kalisvar Marimuthu1,2, Po-Ying Chia1,2, Vanessa Koh1,2, Calvin J Chiew3, Liang De Wang4, Barnaby E Young4, Monica Chan4, Shawn Vasoo4, Li-Min Ling4, David C Lye4, Kai-Qian Kam5, Koh-Cheng Thoon5, Lalitha Kurupatham3, Zubaidah Said3, Ethan Goh3, Constance Low3, Soon-Kok Lim3, Pream Raj3, Olivia Oh3, Valerie T J Koh3, Cuiqin Poh3, Tze-Minn Mak4, Lin Cui4, Alex R Cook6, Raymond T P Lin7, Yee-Sin Leo7, Vernon J M Lee8.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32163698      PMCID: PMC7121487          DOI: 10.1056/NEJMc2003100

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
To the Editor: As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections (causing coronavirus disease 2019 [Covid-19]) spread globally, uncertainty surrounds estimates of the true number of infected persons, which is crucial to determining the severity of infection and the incidence of mild or asymptomatic cases and their possible transmission.[1] Modeling estimates suggest that in Wuhan, China, the city with the most Covid-19 cases, there are substantially more cases than were officially reported, because milder cases may not have been captured in hospital-based surveillance.[2,3] Data on travelers returning from areas with cases of Covid-19 could be useful in estimating its incidence.[4] We followed up on 94 persons who boarded an evacuation flight from Wuhan to Singapore on January 30, 2020. Screening for body temperature was conducted at check-in and before boarding, and 3 febrile persons were prevented from boarding (Figure 1); no additional information regarding the status of these 3 febrile persons was available. Surgical masks were provided to passengers on board the plane. On arrival in Singapore, the passengers underwent repeat screening for body temperature (fever was defined as a body temperature ≥38°C), and 2 persons (a woman 48 years of age [Patient 1] and a woman 47 years of age [Patient 2]) had a fever. The 2 febrile women were transferred immediately to a hospital, and they tested positive for SARS-CoV-2 (their clinical course is described in the Supplementary Appendix, available with the full text of this letter at NEJM.org).
Figure 1

Follow-up of 94 Persons who Boarded an Evacuation Flight from Wuhan, China, to Singapore on January 30, 2020.

Of the 6 persons who had been transferred to a hospital before February 2, 2020, 3 returned to the government quarantine facility and are included with the 87 persons who underwent testing at the facility on quarantine day 6 (February 5, 2020). SARS-CoV-2 denotes severe acute respiratory syndrome coronavirus 2.

The remaining 92 afebrile passengers (age range, 2 to 82 years) were quarantined for 14 days at a government quarantine facility, where they were checked for symptoms and fever three times daily. Six persons reported symptoms (4 on quarantine day 2 and 2 on quarantine day 3) and were placed in isolation in a hospital and underwent polymerase-chain-reaction (PCR) testing; all 6 persons tested negative for SARS-CoV-2. On quarantine day 3, samples from 76 of the 86 asymptomatic persons (75 nasopharyngeal swab samples and 1 nasal swab sample) were obtained and tested by means of PCR assay. A 17-year-old boy (the son of Patient 1) tested positive for Covid-19 and continued to have PCR-positive status for 2 weeks, and a 41-year-old man had an inconclusive result (positive for N gene and negative for ORF1ab gene). On quarantine day 6, samples from all 87 quarantined asymptomatic persons (85 nasopharyngeal swab samples and 2 nasal swab samples [3 of the 6 persons who had been transferred to the hospital before February 2 had returned to the government quarantine facility]) were obtained and tested; all tested negative. All persons who were not isolated in the hospital were released from quarantine on day 14, and all remained uninfected with Covid-19. Understanding the implications of transmission of SARS-CoV-2 infection from persons with asymptomatic or very mild symptomatic cases of Covid-19 is vital for the formulation of containment strategies.
  2 in total

1.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.

Authors:  Joseph T Wu; Kathy Leung; Gabriel M Leung
Journal:  Lancet       Date:  2020-01-31       Impact factor: 79.321

2.  Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China.

Authors:  Sebastian Hoehl; Holger Rabenau; Annemarie Berger; Marhild Kortenbusch; Jindrich Cinatl; Denisa Bojkova; Pia Behrens; Boris Böddinghaus; Udo Götsch; Frank Naujoks; Peter Neumann; Joscha Schork; Petra Tiarks-Jungk; Antoni Walczok; Markus Eickmann; Maria J G T Vehreschild; Gerrit Kann; Timo Wolf; René Gottschalk; Sandra Ciesek
Journal:  N Engl J Med       Date:  2020-02-18       Impact factor: 91.245

  2 in total
  48 in total

1.  Unmasking the mask: the role of personal protective equipment for ophthalmologists caring for asymptomatic patients during the COVID-19 pandemic.

Authors:  Adrian T Fung
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

2.  Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic.

Authors:  Aly-Khan A Lalani; Kim N Chi; Daniel Y C Heng; Christian K Kollmannsberger; Srikala S Sridhar; Normand Blais; Christina Canil; Piotr Czaykowski; Sebastien J Hotte; Nayyer Iqbal; Denis Soulières; Dominick Bossé; Nimira S Alimohamed; Naveen S Basappa; Som D Mukherjee; Eric Winquist; Lori A Wood; Scott A North
Journal:  Can Urol Assoc J       Date:  2020-04-05       Impact factor: 1.862

Review 3.  Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature.

Authors:  Enrico Scala; Luca Fania; Filippo Bernardini; Rodolfo Calarco; Sabrina Chiloiro; Cristiana Di Campli; Sabrina Erculei; Mauro Giani; Marzia Giordano; Annarita Panebianco; Francesca Passarelli; Andrea Trovè; Sofia Verkhovskaia; Giandomenico Russo; Antonio Sgadari; Biagio Didona; Damiano Abeni
Journal:  Immun Inflamm Dis       Date:  2021-05-04

4.  International travel-related control measures to contain the COVID-19 pandemic: a rapid review.

Authors:  Jacob Burns; Ani Movsisyan; Jan M Stratil; Renke Lars Biallas; Michaela Coenen; Karl Mf Emmert-Fees; Karin Geffert; Sabine Hoffmann; Olaf Horstick; Michael Laxy; Carmen Klinger; Suzie Kratzer; Tim Litwin; Susan Norris; Lisa M Pfadenhauer; Peter von Philipsborn; Kerstin Sell; Julia Stadelmaier; Ben Verboom; Stephan Voss; Katharina Wabnitz; Eva Rehfuess
Journal:  Cochrane Database Syst Rev       Date:  2021-03-25

5.  Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic.

Authors:  Nathan W Furukawa; John T Brooks; Jeremy Sobel
Journal:  Emerg Infect Dis       Date:  2020-06-21       Impact factor: 6.883

6.  Key questions for modelling COVID-19 exit strategies.

Authors:  Robin N Thompson; T Déirdre Hollingsworth; Valerie Isham; Daniel Arribas-Bel; Ben Ashby; Tom Britton; Peter Challenor; Lauren H K Chappell; Hannah Clapham; Nik J Cunniffe; A Philip Dawid; Christl A Donnelly; Rosalind M Eggo; Sebastian Funk; Nigel Gilbert; Paul Glendinning; Julia R Gog; William S Hart; Hans Heesterbeek; Thomas House; Matt Keeling; István Z Kiss; Mirjam E Kretzschmar; Alun L Lloyd; Emma S McBryde; James M McCaw; Trevelyan J McKinley; Joel C Miller; Martina Morris; Philip D O'Neill; Kris V Parag; Carl A B Pearson; Lorenzo Pellis; Juliet R C Pulliam; Joshua V Ross; Gianpaolo Scalia Tomba; Bernard W Silverman; Claudio J Struchiner; Michael J Tildesley; Pieter Trapman; Cerian R Webb; Denis Mollison; Olivier Restif
Journal:  Proc Biol Sci       Date:  2020-08-12       Impact factor: 5.349

7.  Development and validation of the OUTCoV score to predict the risk of hospitalisation among patients with SARS-CoV-2 infection in ambulatory settings: a prospective cohort study.

Authors:  Frederique Jacquerioz; Stéphanie Baggio; Angele Gayet-Ageron; François Chappuis; Laurent Getaz; Idris Guessous; Laurent Kaiser; Nathalie Vernaz; Sabine Yerly; Julien Salamun; Herve Spechbach
Journal:  BMJ Open       Date:  2021-06-18       Impact factor: 2.692

8.  Pneumatosis Intestinalis in the Setting of COVID-19: A Single Center Case Series From New York.

Authors:  Santiago J Miyara; Lance B Becker; Sara Guevara; Claudia Kirsch; Christine N Metz; Muhammad Shoaib; Elliot Grodstein; Vinay V Nair; Nicholas Jandovitz; Alexia McCann-Molmenti; Kei Hayashida; Ryosuke Takegawa; Koichiro Shinozaki; Tsukasa Yagi; Tomoaki Aoki; Mitsuaki Nishikimi; Rishabh C Choudhary; Young Min Cho; Stavros Zanos; Stefanos Zafeiropoulos; Hannah B Hoffman; Stacey Watt; Claudio M Lumermann; Judith Aronsohn; Linda Shore-Lesserson; Ernesto P Molmenti
Journal:  Front Med (Lausanne)       Date:  2021-06-04

9.  Transmission frequency of COVID-19 through pre-symptomatic and asymptomatic patients in AJK: a report of 201 cases.

Authors:  Majid Mahmood; Noor-Ul-Ain Ilyas; Muhammad Faraz Khan; Muhammad Naseem Hasrat; Nicholas Richwagen
Journal:  Virol J       Date:  2021-07-03       Impact factor: 4.099

10.  Cutaneous manifestations in hospitalized patients diagnosed as COVID-19.

Authors:  Ozge Askin; Rozerin Neval Altunkalem; Dursun Dorukhan Altinisik; Tugba Kevser Uzuncakmak; Umit Tursen; Zekayi Kutlubay
Journal:  Dermatol Ther       Date:  2020-07-31       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.